Pfizer CEO Profits After COVID Vaccine Announcement

Eyebrows raised when Pfizer CEO sold some of his holdings in the company to the tune of $5.6 million. The prescheduled sale came at the perfect time, when the company publicly announced promising results from early COVID vaccine trials. CNBC reports that Bourla’s base salary was $1.65 million in April. After his most recent sale of shares, he still owns nine times his salary in shares, approximately $15 million.

MarketScale Radio hosts Daniel Litwin and Tyler Kern dissect the news. Litwin considers the serendipity of the sale timed with the public announcement. Kern and Litwin consider the thought of one person profiting tremendously off of a public good like a life-saving vaccine, and in the end, Kern points out, any one takeaway depends on how one feels about capitalism’s economic structures and incentives.

KEY POINTS:

  • Pfizer CEO Albert Bourla sells $5.6 million worth of stock just as it jumps 15%.
  • The sale was pre-scheduled, but opportunely timed with the public announcement of a promising vaccine.
  • Other medical executives at Moderna also are cashing in on spiking stocks while vaccines inch toward approval.

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

farm
The Business Case for AgTech: Better Data Is Key to Managing Risk on the Farm
April 23, 2026

Farming is under more pressure than it’s been in years. Costs are rising, prices are unpredictable, and every decision carries more weight than it used to. What many still think of as a traditional industry is quietly evolving, with more farmers turning to digital tools to manage risk and stay competitive. It’s not about chasing…

Read More
pre-clinical
From Classroom to Clinic: Pre-Clinical Talent Steps Into Healthcare’s Hard-to-Fill Roles
April 23, 2026

Healthcare systems are facing a workforce crisis that’s no longer temporary—it’s structural. Even before COVID-19, staffing shortages across nursing, technical, and administrative roles were already straining capacity; today, those gaps are wider, costlier, and directly impacting patient access. With labor shortages persisting and burnout rising, health systems are being forced to rethink not just…

Read More
learning
If Higher Ed Wants Experiential Learning at Scale, It Needs a Broader Playbook
April 21, 2026

The ground is shifting under higher education. AI is changing how people learn almost overnight—and at the same time, more than half of graduates are underemployed after finishing their degrees. That’s forcing a more uncomfortable question into the open: what is a college credential really worth today? As employers and governments shift their focus…

Read More
skilled trades mentorship
Why the Modern Data Center Is Forcing Communities and Policymakers to Rethink Infrastructure
April 21, 2026

Data centers have moved from largely invisible digital infrastructure to a highly visible source of public debate as artificial intelligence accelerates demand for power, fiber, and compute capacity. The modern data center is now being built closer to population centers to support low-latency services, bringing critical infrastructure into direct contact with residential communities for…

Read More